Vagus Nerve Stimulator Approved for epilepsy; approval sought for treatment- resistant depression Randomized, controlled trial: 15% vs. 10% response r
{"Image DocumentName": "Vagus Nerve Stimulator", "Image ImageDescription": "Approved for epilepsy; approval sought for treatment-resistant depression. Randomized, controlled trial: 15% vs. 10% response rate at 12 weeks (NS) Non-randomized, non-concurrent, unblinded: 30% vs. 13% response rate at 2 years on 20 outcome (P<0.05) 2004: FDA scientists overrule favorable AC vote. 2005: Device Center chief signs approval letter. 2006: Senate Finance Committee investigation shows all 20 reviewing scientists opposed approval. 2007: CMS denies reimbursement.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}